Logo, Chicago Pulmonary Specialists - Pulmonary Specialist 

 (847) 998-3434
2401 Ravine Way, Suite 302, Glenview, IL 60025

Our Philosophy         Pioneering CF Care         Private Practice        Continuity of Care       Office Policies          Diagnostics

Newborn Screening        CF Hotline        CF Testing        Cutting Edge Research        Sharing Our Knowledge        Advocacy       A CF Leader

   Dr. Boas        Assessing Ourselves         Home


Publications


For many years, Dr. Boas has been at the forefront of scholarly research involving cystic fibrosis and other pulmonary conditions.  He has authored over 25 journal articles as well as several chapters in a broad spectrum of highlyrespected medical publications.  Dr. Boas is on the leading edge of all advances in CF care.

Journals

  •          American Journal of Respiratory & Critical Care Medicine
  •          Annals of Allergy, Asthma & Immunology
  •          Chest
  •          Circulation
  •          Clinical Pediatrics
  •          Enzyme
  •          Gastroenterology
  •          International Journal of Sports Medicine
  •          Journal of Adolescent Health
  •          Journal of Asthma
  •          Journal of Cystic Fibrosis
  •          Journal of Pediatrics
  •          Medicine and Science in Sports and Exercise
  •          Pediatric Pulmonology
  •          Pediatrics
  •          Sports Medicine

 

JOURNAL ARTICLES

Osiecki-Newman K, Fabbro D, Dinu T, Boas SR, Gatt S, Legler G, Desnick R, and Grabowski G. Human Acid Beta Glucosidase: Affinity purification of the normal and Gaucher splenic enzymes on n-alkyl deoxynorjirmycin sepharose. Enzyme 1986; 35:147-153.

Boas SR, Noyes BE, Kurland G, Armitage J, and Orenstein DM. Pediatric lung transplantation for graft-versus-host disease following bone marrow transplant. Chest 1994; 105:1584-1586.

Boas SR, Charron M, Ledesma-Medina J, Noyes BE, and Kurland G. Hypertrophic osteoarthropathy in a child with follicular bronchiolitis. Clin Nuclear Med 1995; 20(1): 49-51.

Boas SR, Falsetti D, Murphy TD, and Orenstein DM. Validity of self-assessment of sexual maturation in adolescents with cystic fibrosis. J Adoles Health 1995; 17:42-45.

Faro A, Kurland G, Michaels MG, Dickman PS, Greally PG, Spichty KJ, Noyes BE, Boas SR, Fricker J, Armitage J, and Zeevi A. Alpha-interferon affects the immune response in post transplant lymphoproliferative disorder. Am J Respir Crit Care Med 1996; 153:1442-1447.

Boas SR, Cleary DA, Lee PA, Orenstein DM. Salivary testosterone levels in male adolescents with cystic fibrosis. Pediatrics 1996; 97:361-363.

Boas SR, Bloom MD, and Bonilla JA. Infantile laryngeal neurofibroma presenting as stridor and dysphagia. Clin Pediatrics 1996; 35:151-153.

Boas SR, Joswiak ML, Nixon PA, Fulton JA, and Orenstein DM. Factors limiting anaerobic performance in adolescent males with cystic fibrosis. Med Sci Sports Exerc 1996; 28:291-298.

Boas SR, Kurland G, Greally PG, and Motoyama EK. Evolution of airway hyperresponsiveness in congenital diaphragmatic hernia. Pediatr Pulmonol 1996; 22:295-304.

Boas SR, Joswiak ML, Kurland G, Nixon PA, O’Connor MJ, Bufalino K, Orenstein DM, and Whiteside TL. Effects of anaerobic exercise on the immune system in 8 to 17 year old trained and untrained males. J Pediatr 1996; 129:846-855.

Zapletal A, Kurland G, Boas Sr, Noyes BE, Greally PG, Faro A, Armitage JM, and Orenstein DM. Airway function tests and vocal cord paralysis in lung transplant recipients. Pediatr Pulmonol 1997; 23:87-94.

Boas SR. Exercise recommendations in individuals with cystic fibrosis. Sports Med 1997; 24:17-37.

Boas Sr, Fulton JA, Koehler AN, Orenstein DM. Nutritional and pulmonary function predictors of delayed puberty in adolescent males with cystic fibrosis; Clin Pediatrics 1998; 37:593-596.

Saini SK, Boas SR, Jerath A, Roberts M, Greenberger PA. Allergic bronchopulmonary mycosis to Fusarium vasinfectum in a child. Ann Allergy Asthma Immunol 1998; 80:377-380.

Boas SR, Danduran MJ, Saini SK. Anaerobic exercise testing in children with asthma. J Asthma 1998; 35:481-487.

Boas SR, Danduran MJ, McColley SA. Parental attitudes about exercise in cystic fibrosis. Int J Sports Med 1999; 20:334-338.

Boas SR, Danduran MJ, McColley SA. Energy metabolism during anaerobic exercise in children with cystic fibrosis and asthma. Med Sci Sports Exerc 1999; 31:1242-1249.

Danduran MJ and Boas SR. Cystic fibrosis and exercise: A case study and clinical application. II Fysioterapista 2000; 6:36-41.

Boas SR, Danduran MJ, McColley SA, Beeman K, O’Gorman MRG. Immune modulation following aerobic exercise in children with cystic fibrosis. Int J Sports Med 2000; 21:294-301.

McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of pulmonary exacerbation. Am J Resp Crit Care Med 2000; 161:1877-1880.

Boas SR, Danduran MJ, McColley SA, McBride A, Crawford S, O’Gorman MRG. Post exercise immune correlates in children with and without cystic fibrosis. Med Sci Sports Exerc 2000; 32:1997-2004.

Bare A, Vankoski SJ, Dias L, Danduran M, Boas S. Independent ambulators with high sacral myelomenigocele: the relation between walking kinematics and energy consumption. Dev Med Child Neurol 2001; 43 (1):16-21.

Boas SR, Nevin MA. The role of exercise in the diagnosis and management of children with pulmonary disorders. Int Sports Med Journal 2001; 2(5).

Paridon SM, Alpert BS, Boas SR, et al. Clinical Stress Testing in the Pediatric Age Group. A statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth. Circulation 2006: 113:1-15.

Boas SR. The evidence for exercise. Pediatr Pulmonol 2008; S31:161-163.

Boas SR, Hageman JR, Ho LT, Liveris M. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis. Journal of Cystic Fibrosis 2009; 9:270-272.

Woodridge JL, Heubi JE, Amaro-Galvez R, Boas SR, et al. Eur-1008 Pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. Journal of Cystic Fibrosis 2009: 8: 405-417

Katz BZ, Boas S, Shiraishi Y, Mears CJ, Taylor R. Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis. J Pediatrics 2010: 157: 468 - 72, 472.e1

Farrell P, Boas SR, Castellani C, et al. CLSI. Newborn screening for Cystic Fibrosis; Approved Guideline. CLSI document I/LA35-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.

Boas SR, Hageman J, Washburn J, Piasecki S, Liveris M. Improvement in quality of sweat testing: Results of a quality improvement program. Lab Medicine 2012: 43,12-4.

 

BOOKS AND BOOK CHAPTERS

Boas SR and Danduran MJ. Chapter 21: Cystic Fibrosis and Exercise. In: Clinical Exercise Physiology. Jon Ehrman (Ed). Champaign, IL: Human Kinetics 2003.

Boas SR and Winnie GB. Chapter 380: Emphysema and Overinflation. In: Nelson Textbook of Pediatrics, Richard Behrman (Ed). Philadelphia, PA: WB Saunders 2004, 17th Edition.

Winnie GB and Boas SR. Chapter 381: Alpha 1 Anti-trypsin Deficiency and Emphysema. In: Nelson Textbook of Pediatrics, Richard Behrman (Ed). Philadelphia, PA: WB Saunders 2004, 17th Edition.

Boas SR. Chapter 382: Bronchiolitis Obliterans. In: Nelson Textbook of Pediatrics, Richard Behrman (Ed). Philadelphia, PA: WB Saunders 2004, 17th Edition.

Boas SR. Chapter 409: Skeletal Disease Influencing Pulmonary Function. In: Nelson Textbook of Pediatrics, Richard Behrman (Ed). Philadelphia, PA: WB Saunders 2004, 17th Edition.

Boas SR and Winnie GB. Chapter 389: Emphysema and Overinflation. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2007, 18th Edition.

Winnie GB and Boas SR. Chapter 390: Alpha 1 Anti-trypsin Deficiency and Emphysema. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2007, 18th Edition.

Boas SR. Chapter 391: Bronchiolitis Obliterans and Other Distal Airway Disease. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2007, 18th Edition.

Boas SR. Chapter 416: Skeletal Disease Influencing Pulmonary Function. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2007, 18th Edition.

Boas SR. Chapter 384: Emphysema and Overinflation. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2011, 19th Edition.

Winnie GB and Boas SR. Chapter 385: Alpha 1 Anti-trypsin Deficiency and Emphysema. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2011, 19th Edition.

Boas SR. Chapter 386: Other Distal Airway Disease. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2011, 19th Edition.

Boas SR. Chapter 411: Skeletal Disease Influencing Pulmonary Function. In: Nelson Textbook of Pediatrics, Robert Kliegman et al (Ed). Philadelphia, PA: WB Saunders 2011, 19th Edition.

 

PROCEEDINGS AND NON-REFEREED PAPERS

1997    Boas, S.R. and S.A. McColley. Advances in Cystic Fibrosis. The Child’s Doctor 1997; 15.

 

EXHIBITS AND AUDIO VISUAL MATERIAL

1995    Boas, S.R. Cystic Fibrosis and Exercise. (A Parent Educational Booklet)

1998    Boas, S.R. Pediatric Flexible Bronchoscopy. A guide for patients and families. (Educational Brochure)

1999    Boas, S.R. Exercise Induced Asthma. (A Parent Educational Booklet)

2002    Cystic Fibrosis Update – a Bimonthly Educational Newsletter – begins ongoing publication

2002    Unique Challenges in School for CF (Newsletter)

2002    Exercise Induced Vocal Cord Dysfunction – A Guide for Patients & Parents

2003    Inhaled Glutathione (Newsletter)

2003    Eating Made Easier – A Parent Guide to Enhancing Your Youngster’s Mealtime Behavior

2003    Pectus Excavatum – An Educational Bronchur on Pectus Excavatum: Diagnosis, Surgery, Non-Surgical Approaches.

2004    Gene Therapy for CF: An Update (Newsletter)

2004    Inhaled Corticosteroids Use in Asthma: Things to Consider (Newsletter)

2004    Infection Control in Cystic Fibrosis

2006    Pediatric Resident Curriculum


PUBLISHED ABSTRACTS

Dr. Boas has conducted significant research on cystic fibrosis and other pulmonary conditions. He has presented his findings at over 45 national and international conferences. 

Presenting Independent Research at National and International Conferences

  •          American Thoracic Society
  •          American College of Sports Medicine
  •          North American Society for Pediatric Exercise Medicine
  •          North American Cystic Fibrosis Conference
  •          American Academy of Pediatrics
  •          Illinois Society of Allergy, Asthma and Immunology
  •          World Asthma Meeting

Boas SR, Kurland G, Noyes BE, Orenstein DM, Atlas AB, and Armitage J. Pneumothorax after transbronchial biopsy in pediatric lung and heart-lung transplant recipients. Am Rev Respir Dis 1993; 147L4) A607. (Presented at the 1993 American Thoracic Society Annual Conference).

Boas SR, Greally P, Kurland G, and Motoyama E. Development of airway reactivity in neonates with congenital diaphragmatic hernia. Am Rev Respir Dis 1994, 149(4) A728. (Presented at the 1994 American Thoracic Society Annual Conference).

Zapletal A., Greally P, Murphy TD, Boas SR, Faro A, Orenstein D, Kurland G, and Armitage J. Airway function tests in the assessment of vocal cord abnormalities in pediatric heart-lung and double-lung transplant recipients. Am Rev Respir Dis 1994, (4) A738. (Presented at the 1994 American Thoracic Society Annual Conference).

Greally P, Zapletal A, Boas SR, Orenstein DM, and Armitage J. Longitudinal responses to beta agonists in pediatric heart lung and double lung transplant recipients. Am Rev Respir Dis 1994, 149:(4) A732. (Presented at the 1994 American Thoracic Society Annual Conference).

Boas SR, Joswiak ML, Bufalino K, O’Connor MJ, Nixon PA, Orenstein DM, and Whiteside TL. Effects of anaerobic exercise on the immune system in 8 to 17 year old trained and untrained males. Med Sci Sports Exerc 1995, 27(5) Supplement. (Presented at the 1995 American College of Sports Medicine Annual Conference).

Boas SR, Nixon PA, Joswiak M, Fulton J, and Orenstein DM. Anaerobic exercise testing in male adolescents with cystic fibrosis. Ped Ex Sci 1995, 7(1):111. (Presented at the 1995 North American Society for Pediatric Exercise Medicine Annual Conference).

Fulton J, Boas S, Koehler A, and Orenstein D. Nutritional and respiratory markers for pubertal development in adolescent males with cystic fibrosis. Ped Pulm 1995, S12: 265. (Presented at the 1995 North American Cystic Fibrosis Foundation National Conference).

Danduran MJ, Boas SR, McColley SA, Gargan J, Wessel HU. Parental attitudes about the benefits and barriers of exercise in children with CF. Ped Pulm 1996, S336-7. (Presented at the 1996 North American Cystic Fibrosis Foundation National Conference).

Sanai S, Boas SR, Danduran MJ. Normal anaerobic exercise capacity in well-controlled asthmatic children. (Presented at the 1997 American Academy of Pediatrics, Section on Allergy and Immunology, 1997 Illinois Society of Allergy, Asthma, and Immunology).

Sanai SK, Boas SR, Danduran MJ. Altered anaerobic exercise capacity in asthmatic children may contribute to impaired exercise tolerance. J Allergy Clin Immun 1997; 99:1672 (Presented at the 1997 AAAAI/AAI/CIS Joint Meeting).

Boas SR, Danduran MJ. Parental understanding about the role of exercise in cystic fibrosis. Am J Resp Crit Care Med 1997, 155:A646. (Presented at the 1997 American Thoracic Society Annual Conference).

Boas SR, Danduran MJ, McColley SA. Preferential use of aerobic pathways during anaerobic exercise in cystic fibrosis. Am J Resp Crit Care Med 1997, 155:A643. (Presented at the 1997 Chicago Thoracic Society Scientific Abstract Session, 1997 American Thoracic Society Annual Conference).

Boas SR, Danduran MJ. Correlation of aerobic and anaerobic exercise in children with cystic fibrosis. Med Sci Sports Exerc 1997; 29:S209. (Presented at the 1997 American College of Sports Medicine Conference).

Bare A, Vankoski S, Dias L, Danduran M, Boas S. Energy expenditure in children with lumbosacral myelomenigocele: What’s the cost of walking? Develop Med Child Neurol 1997; 39 (Suppl 75): 18. (Presented at the 1997 American Academy for Cerebral Palsy and Developmental Medicine Annual Meeting).

Bare A, Vankoski S, Dias L, Danduran M, Boas S. Energy expenditure in children with lumbosacral myelomenigocele: What’s the cost of walking? Gait and Posture 1997;5: 142-143. (Presented at the 1997 North American Society for Gait and Clinic Movement Analysis).

Vankowski S, Bare BS, Dias L, Mitchaud S, Danduran M, Boas S. Energy expenditure, kinematics, and the center of mass during walking in children with lumbosacral myelomenigocele. Gate and Posture 1997; 6:279-280.

Boas SR, Salazar JM, Danduran MJ, McColley SA. Effects of “Breakpoints” in normative values for pulmonary function in patients with cystic fibrosis. Am J Resp Crit Care Med 1998; 157:A128. (Presented at the 1998 Chicago Thoracic Society Scientific Abstract Session, 1998 American Thoracic Society Conference).

Boas SR, Salazar JM, Danduran MJ, McColley SA. Diurnal variations in pulmonary function within the cystic fibrosis population. Am J Resp Crit Care Med 1998, 157:A128. (1998 American Thoracic Society Conference).

Boas SR, Chen RC, Danduran MJ, McColley SA, O’Gorman MRG, Woods JA, Post exercise immune modulation in children with cystic fibrosis. Am J Resp Crit Care Med 1998; 157:A128. (Presented at the 1998 Chicago Thoracic Society Scientific Abstract Session, 1998 American Thoracic Society Conference).

McColley SA, Boas SR, Jain M, Qualter NA, O’Malley CA. patient adherence to and treatment satisfaction with an airway clearance technique. Ped Pulm 1998, Suppl 17:389. (Presented at the 1998 North American Cystic Fibrosis Foundation Annual Conference).

McColley SA, Stellmach V, Potter E, Huang J, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor 9VGED) is elevated in cystic fibrosis and is modulated by treatment of acute pulmonary exacerbations. Ped Pulm 1998, Suppl 17:317. (Presented at the 1998 North American Cystic Fibrosis Foundation National Conference).

Boas SR, Schulz C, Weissberg-Benchell J, Martini DR, McColley SA. Psychological screening in female adolescents with cystic fibrosis. Ped Pulm 1998, Suppl 17:394. (Presented at the 1998 North American Cystic Fibrosis Foundation National Conference).

Boas SR, Danduran MJ, Woods JA, O’Gorman MRG, McColley SA. Post exercise catecholamine induced immunemodulation in children with cystic fibrosis. Ped Ex Sci 1999, 11(2):180. (1998 North American Society for Pediatric Exercise Medicine Conference).

Danduran MJ, Boas SR, McBride AL. Biphasic responses to exercise appear compromised in children with chronic pulmonary disorders. Med Sci Sports Exerc 1999, 31(5):S330. (Presented at the 1999 American College of Sports Medicine Annual Conference).

McBride AL, Boas SR, Danduran MJ, Crawford, Huang L, McColley SA. Serum vascular endothelial growth factor correlates with fitness level in cystic fibrosis. Med Sci Sports Exerc 1999, 31(5): S270. (Presented at the 1999 American College of Sports Medicine Annual Conference).

McColley SA, Schulz C, Qualter N, Boas SR, Jain M, Goodman DM. Participation in an observational study of airway clearance in cystic fibrosis does not influence patient adherence. Ped Pulm 1999, Suppl 19:331. (Presented at the 1999 North American Cystic Fibrosis Foundation National Conference).

McColley SA, Harris CV, Qualter N, O’Malley C, Boas SR, Jain M. Predictors of adherence to an airway clearance technique in cystic fibrosis. Ped Pulm 1999, Suppl 19:332. (Presented at the 1999 North American Cystic Fibrosis Foundation National Conference).

McColley SA, Singhal A, Boas SR, Goodman DM. Inhaled colistin for treatment of pulmonary exacerbation of cystic fibrosis. Am J Resp Crit Care Med 2000, 161 (3):A73. (Presented at the 2000 American Thoracic Society International Conference).

McBride AL, Danduran MJ, McColley SA, Boas SR. Is FEV1 a good predictor of exercise tolerance in individuals with cystic fibrosis. Ped Exerc Sci 2001, 13:87-88. (Presented at the 2000 North American Society for Pediatric Exercise Medicine International Conference).

Danduran MJ, McBride AL, Holinger LD, Boas SR. Case report: Unexplained dyspnea in a competitive female swimmer. Ped Exerc Sci 2001,13:188. (Presented at the 2000 North American Society for Pediatric Exercise Medicine International Conference).

Boas SR, Young J, McBride AM, McColey SA. The role of mirtazapine as an appetite stimulant in children with cystic fibrosis. Ped Pulm 2000, Suppl 20:325-326. (Presented at the 2000 North American Cystic Fibrosis Foundational National Conference).

Boas SR, Salazar JM, McBride AL, Trousil JD. Feasability and tolerance of simultaneous exercise and cold air provocation in children with asthma. Am J Resp Crit Care Med 2001; 163 (5):A369. (Presented at the 2001 American Thoracic Society Annual Conference).

McBride AL, Boas SR, Trousil J, McColley SA. The utility of flow volume loop analysis during exercise in children with cystic fibrosis. Med Sci Sports Exerc 2001, 33(5):S250. (Presented at the 2001 American College of Sports Medicine Annual Meeting).

Altemus C, Boas SR, Mesnik. Utilization of exercise tidal loop analysis in children with exercise induced asthma. (Presented at the 2001 World Asthma Meeting).

Miller ML, Boas SR. Evidence for deconditioning in children with musculoskeletal pain syndromes. Arthritis Rheum 2001, 44(9):S171. (2001 American Rheumatology Meeting).

Boas SR, Talley AM, McBride AL, Mesnik MN. Montelukast attenuates pulmonary decline during combined cold air/exercise provocations in children with mild asthma. Med Sci Sports Exerc 2002, 34(5):S13. (Presented at the 2002 American College of Sports Medicine Annual Meeting).

Trivunobic M, Miller ML, Mesnik M, Boas SR. Evidence for deconditioning in children with musculoskeletal pain syndromes. Med Sci Sports Exerc 2002, 34(5):S13. (Presented at the 2002 American College of Sports Medicine Annual Meeting).

Mesnik MN, Boas SR. Early recovery oxygen kinetics following a peak cardiopulmonary exercise test in children with cystic fibrosis. Med Sci Sports Exerc 2002, 34(5)S14. (Presented at the 2002 American College of Sports Medicine Annual Meeting).

Boas S, Shoberg D. Quality improvement initiatives in CF health care delivery: Preliminary results. Pediatr Pulm 2004, S24:350. (Presented at the 2004 North American Cystic Fibrosis Foundation National Conference).

Boas S, Choudhury N, Urben AJ. Impact of CF Genotype on Exercise Performance. Pediatr Pulm 2005, S28:306. (Presented at the 2005 North American Cystic Fibrosis Foundation National Conference).

Bever JC, Boas SR. Use of tidal loop analysis in suspected pediatric exercise induced vocal cord dysfunction. Med Sci Sports Exerc 2006, 38(5):S384. (Presented at the 2006 American College of Sports Medicine Annual Meeting).

Boas SR, Bever J, Bicchinella M, Liveris M. Breathing strategies during maximal exercise testing is related to lung disease severity for people with CF. Pediatr Pulm 2006, S29:353. (Presented at the 2006 North American Cystic Fibrosis Foundation National Conference).

Bichinnella, Lading K, Ho LT, Boas SR. A high dose ergocalciferol regimen corrects vitamin D deficiency for individuals with cystic fibrosis: A quality improvement initiative. Pediatr Pulm 2007, S30:383. (Presented at the 2006 North American Cystic Fibrosis Foundation National Conference).

Heubi J, Boas SR, Blake K et al. Eur-1008, A PEP, is safe and effective in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI). Pediatr Pulm 2007, S30:39s. (Presented at the 2007 North American Cystic Fibrosis Foundation National Conference).

Boas SR, Hageman J, Liveris M. Haller index does not predict physiologic abnormalities in children and adolescents with pectus excavatum. Med Sci Sports Exerc 2008, 40(5):S1455. (Presented at the 2008 American College of Sports Medicine Annual Meeting).

Boas SR, Bicchinella M, Liveris M, Hageman J. A “Normal” FEV1 is a poor predictor of exercise tolerance in individuals with cystic fibrosis. Pediatr Pulm 2008, S31:384. (Presented at the 2008 North American Cystic Fibrosis Conference).

Katz BZ, Boas SR, Shiraishi Y, Mears CJ, Taylor R. Exercise tolerance testing is a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis. (Presented at the 2009 Infectious Disease Society Annual Conference).

Boas SR, Wolk RL, Wood L, Service A. Use of ultrasonography in body composition assessment in cystic fibrosis and pediatric patients. Med Sci Sports Exerc 2010, 42(5): S24. (Presented at the 2010 American College of Sports Medicine Annual Meeting).

Oermann CM, Assael B, Nakamura C, Boas SR, et al. Aztreonam for inhalation solution (AZLI) vs. tobramycin inhalation solution (TIS), A 6-month comparative trial in cystic fibrosis patients with pseudomonas aeruginosa. Pediatr Pulm 2010, S33:327. (Presented at the 2010 North American Cystic Fibrosis Conference).

Boas SR, Hageman J, Liveris M, Washburn J, Piasecki S. Improvement in quality of sweat testing: Results of a quality improvement program. Pediatr Pulm 2011, S34:366. (Presented at the 2011 North American Cystic Fibrosis Conference).